youtube_live
Q3 2026 earnings • released • EPS beat +17,23% • Revenue beat +8,09%
See resultschevron_right
INDV:NASDAQ
Indivior Pharmaceuticals Inc
35,37 $
arrow_upward
+0,34%(+0,12) 1D
30 հոկ, 15:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
34,78 $
High
36,49 $
Low
34,62 $
Mkt. cap
4,17 մլրդ
Avg. vol.
2,44 մլն
Volume
0,00
P/E ratio
12,73
52-wk high
42,81 $
52-wk low
27,68 $
EPS
2,78 $
Beta
1,10
Shares outstanding
118,04 մլն
No. of employees
833
Open
34,78 $
High
36,49 $
Low
34,62 $
Mkt. cap
4,17 մլրդ
Avg. vol.
2,44 մլն
Volume
0,00
P/E ratio
12,73
52-wk high
42,81 $
52-wk low
27,68 $
EPS
2,78 $
Beta
1,10
Shares outstanding
118,04 մլն
No. of employees
833
News stories
From web sources and news partners
The Dark Side Of The Boom
·
10 րոպե առաջ
Wall Street's AI Unwind: Goldman Finds Seven Signs the Selling May Be Running Out of Road
TradingView
·
41 րոպե առաջ
IXIC: Nasdaq Futures Rebound with Apple Earnings, US Midterm Elections Ahead
bloomingbit
·
44 րոպե առաջ
Morgan Stanley's Wilson Says US Stock Pullback Is Buying Opportunity, Sees S&P 500 Rising From 7,100 to 8,000
The New York Times
·
6 ժամ առաջ
After Tech Sell-Off, Investors Brace for More Market Volatility
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc